Quantity of delta‐9‐tetrahydrocannabinol consumption and cannabis use disorder among daily cannabis consumers
Addiction · 2025-04 · 120 (4) · 676-685
DOI: 10.1111/add.16700 ↗Kurz gefasst
Fachartikel in der Zeitschrift Addiction, online erschienen am 06.11.2024. Verfasst von Jacob T Borodovsky und 9 weiteren Autor:innen. Beteiligte Einrichtung: Center for Technology and Behavioral Health, Dartmouth Geisel School of Medicine, Lebanon, NH, USA. Hauptthemen laut MEDLINE: Dronabinol, Marijuana Abuse. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDA NIH HHS, National Institute on Drug Abuse.
Abstract (Originalsprache)
Background and aims Amid escalating cannabis legalization and daily consumption in the United States (US), determining the risk of cannabis use disorder (CUD) and relevant consequences among daily consumers has become a public health priority. Understanding these risks requires valid assessment of the daily quantity of delta‐9‐tetrahydrocannabinol (THC) consumed and its relation to consequences. This study characterized daily cannabis consumption using a new method for estimating milligrams of THC (mgTHC), and examined the relationship between daily mgTHC and CUD severity in a large national sample of daily consumers. Design, setting and participants US adult (aged 18+ years) daily cannabis consumers ( n = 4134) completed a comprehensive online survey of cannabis consumption patterns (e.g. frequency, quantity, product types, potencies, administration methods) and Diagnostic and Statistical Manual of Mental Disorders , 5th edition (DSM‐5) CUD criteria.
Measurements
The primary exposure was past‐week daily mgTHC consumption, calculated from survey responses to queries about product type, amount and potency consumed and including adjustments for puff size and loss of THC from specific methods of administration. The primary outcomes were (1) number of CUD criteria (range = 0–11) and (2) CUD severity categories: none, mild, moderate, severe.
Findings
Median daily consumption was ~130 mgTHC, with substantial variability (25% ≤ 50 mg and 25% ≥ 290 mg). On average, participants endorsed 2.5 CUD criteria, and 65% met criteria for CUD (39% mild, 18% moderate, 8% severe). Greater daily mgTHC predicted higher CUD criteria count [beta log(mgTHC) = 0.50, 95% confidence interval (CI) = 0.267–0.734] and higher odds of mild [log odds ratio (logOR) = 0.238, 95% CI = 0.184–0.292], moderate (logOR = 0.303, 95% CI = 0.232–0.374) or severe (logOR = 0.335, 95% CI = 0.236–0.435) CUD.
Conclusions
Among daily consumers of cannabis, there appears to be a positive relationship between the daily quantity of cannabis consumed (measured in milligrams of delta‐9‐tetrahydrocannabinol) and both the risk and severity of cannabis use disorder.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center for Technology and Behavioral Health, Dartmouth Geisel School of Medicine, Lebanon, NH, USA.
- Department of Biomedical Data Science, Dartmouth Geisel School of Medicine, Lebanon, NH, USA.
- Department of Psychiatry, Columbia University Irving Medical Center, New York, NY, USA.
- Department of Epidemiology, Columbia University Mailman School of Public Health, New York, NY, USA.
- Department of Biostatistics, Columbia University Mailman School of Public Health, New York, NY, USA.
- New York State Psychiatric Institute, New York, NY, USA.
ORCID-Profile: Jacob T Borodovsky, Deborah S Hasin, Ofir Livne
Förderung
- NIDA NIH HHS
- National Institute on Drug Abuse
Zitieren
APA
Borodovsky, J. T., Hasin, D. S., Wall, M., Struble, C. A., Habib, M. I., Livne, O., Liu, J., Chen, L., Aharonovich, E., & Budney, A. J. (2025). Quantity of delta‐9‐tetrahydrocannabinol consumption and cannabis use disorder among daily cannabis consumers. Addiction, 120(4), 676-685. https://doi.org/10.1111/add.16700
Vancouver
Borodovsky JT, Hasin DS, Wall M, Struble CA, Habib MI, Livne O, et al. Quantity of delta‐9‐tetrahydrocannabinol consumption and cannabis use disorder among daily cannabis consumers. Addiction. 2025;120(4):676-685. doi:10.1111/add.16700
BibTeX
@article{Borodovsky2025,
author = {Borodovsky, Jacob T and Hasin, Deborah S and Wall, Melanie and Struble, Cara A and Habib, Mohammad I and Livne, Ofir and Liu, Jun and Chen, Lynn and Aharonovich, Efrat and Budney, Alan J},
title = {Quantity of delta‐9‐tetrahydrocannabinol consumption and cannabis use disorder among daily cannabis consumers},
journal = {Addiction},
year = {2025},
volume = {120},
number = {4},
pages = {676--685},
doi = {10.1111/add.16700}
}
EUVIMED